Latest in Cardiology from ACC.org

• 20-Year Outcomes For PVI in Patients With Drug-Refractory Paroxysmal AFib
  Twenty years after pulmonary vein isolation (PVI) during catheter ablation, stable sinus rhythm was maintained in a quarter of patients with symptomatic drug-refractory paroxysmal atrial fibrillation (PAF), including those taking antiarrhythmic drugs and those who had multiple ablation procedures, according to findings from a study published Feb. 17 in JACC: Clinical Electrophysiology.
• AI-Enabled Clinician: Access to and Implementation of AI-Quantified Plaque Analysis Technology
  In this episode, ACC Chief Innovation Officer Dr. Ami Bhatt is joined by Dr. Geoffrey Rose to explore the impact of artificial intelligence (AI)-enabled plaque analysis and its integration into clinical workflows.
• ACC Efforts Help Propel Legislation to Stabilize Medicare Physician Payments
  Establishing sustainable Medicare payment practices has long been a top priority for ACC Advocacy, and key bills introduced in Congress offer a promising pathway toward real, lasting reform.
• ESC 0/1-Hour Algorithm vs. High-STEACS 0/2-Hour or 0/3-Hour Pathway For NSTEMI Diagnosis
  Both the European Society of Cardiology 0/1-hour algorithm (ESC 0/1h-algorithm) and the high-sensitivity troponin in the evaluation of patients with acute coronary syndrome 0/2-hour or 0/3-hour pathway (High-STEACS 0/2h-0/3h-pathway) demonstrated "comparable and excellent performance" in diagnosing patients presenting with acute chest discomfort, according to a prospective, multicenter study published in JACC.
• Turning Strategy Into Action: Highlights From the January BOT Meeting
  Transparency, shared understanding and bidirectional communication are critical to strong governance. Coming out of the recent January Board of Trustees (BOT) meeting at Heart House, I wanted to share key takeaways to help guide our collective efforts to achieve our Mission, Vision and Strategic Plan.